Trial Outcomes & Findings for Comparison of Oral Gabapentin and Pregabalin in Postoperative Pain Control After Photorefractive Keratectomy (NCT NCT00954187)

Results Overview

No data was collected or analyzed. No study procedures were performed.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

8 participants

Primary outcome timeframe

one month

Results posted on

2017-01-09

Participant milestones
Measure	Gabapentin Neurontin Gabapentin: Gabapentin - 300 mg three times a day starting two hours prior to surgery and will continue for a total of four days	Pregabalin Lyrica pregabalin: 50 mg PO TID
Overall Study STARTED	0	0
Overall Study COMPLETED	0	0
Overall Study NOT COMPLETED	0	0

Withdrawal data not reported

Comparison of Oral Gabapentin and Pregabalin in Postoperative Pain Control After Photorefractive Keratectomy

Baseline characteristics by cohort
Measure	Gabapentin Neurontin Gabapentin: Gabapentin - 300 mg three times a day starting two hours prior to surgery and will continue for a total of four days	Pregabalin Lyrica pregabalin: 50 mg PO TID	Total Total of all reporting groups
Gender Female	—	—	0 n=5 Participants
Gender Male	—	—	0 n=5 Participants

Timeframe: one month

Population: No subjects were assigned treatment and no study procedures were performed

No data was collected or analyzed. No study procedures were performed.

Outcome data not reported

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

Loma Linda University

Phone: 9095589408